AACR-Male Breast Cancer Global Alliance-Daryl and Christine Soneral Innovation and Discovery Grant for Male Breast Cancer Research supports investigators researching male breast cancer to advance treatment.
Funder: American Association for Cancer Research
Due Dates: January 12, 2027, at 1:00 p.m. U.S. Eastern Time (Application) | June 2027 (Notification) | July 1, 2027 (Grant start)
Funding Amounts: $50,000 USD over one year
Summary: Supports independent investigators conducting innovative basic, translational, or clinical research directly relevant to male breast cancer.
Key Information: Applicants must meet AACR Active Membership requirements by the submission deadline.
This joint initiative of the American Association for Cancer Research (AACR), Male Breast Cancer Global Alliance, and Daryl and Christine Soneral supports independent investigators advancing male breast cancer biology and translating promising discoveries into clinical impact. Projects may be basic, translational, or clinical and must address a significant unmet need through innovative, hypothesis-driven research.
Research should generate novel biological insights supporting therapeutic development, biomarker discovery, or precision medicine. Relevant work includes elucidating disease mechanisms, identifying or validating therapeutic targets and biomarkers, characterizing treatment response or resistance, and developing translational strategies. Any aspect of male breast cancer is welcome, with preference for metastatic disease. Projects primarily replicating established research without substantial innovation, or lacking clear male breast cancer relevance, are outside scope.